{"id":999740,"date":"2026-09-02T08:41:43","date_gmt":"2026-09-02T12:41:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"},"modified":"2026-09-02T08:41:43","modified_gmt":"2026-09-02T12:41:43","slug":"kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","title":{"rendered":"Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN FRANCISCO, Sept.  02, 2026  (GLOBE NEWSWIRE) &#8212; Kyntra Bio (Nasdaq: KYNB) today announced that the company\u2019s management will be attending and presenting at the H.C. Wainwright 28<sup>th<\/sup> Annual Global Investment Conference being held September 14-16, 2026, in New York, NY.<\/p>\n<p align=\"justify\">Thane Wettig, Chief Executive Officer of Kyntra Bio, will deliver a company presentation on Tuesday, September 15 at 4:00 PM ET. A live webcast of the presentation will be available\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=24je3FODPlkQsvC7tA-ZD8gG3B3wP2TYB77x0KjaVTCOvaZYRD0SiXkS5UROosdRw8xYA_vQgDKN30aqhlT406SYxzxLTWfzFjtso0W34SRHK67XHQcEz8tolQQk9B0sxDe8fvBE-EiTrVNNnqzGQg==\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p>Kyntra Bio\u2019s management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright. The live audio webcast of the event will also be available to investors and other interested parties on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VZ31_qMkMchG0g7uzfQtvduQZ2OAu1S0-B6orK6Ch7vn3lQT2Utp0uUyjY_abd5gZ4iMT5r-v5lkb9T5EE3aTY_LsdST7sLbhmFf2jFXDID7qDOjd6CCmBzXDRnDl6J3ccxolZanIfkjvtkU1Hp9N5SgGIBwM9uhdt9Ol2k1S0E=\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a>\u201d section of the Kyntra Bio Investor webpage at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mp-DwgX7nkE40q50poVdy1BW1SOcuOV11CqIl6TIuySpbZJx76NJke-Uuh1l0QYYlUMPX69nL1K7h_Uy1oM1wT-IRYp4uZkpIEiFHiap4kg=\" rel=\"nofollow\" target=\"_blank\">www.kyntrabio.com<\/a>. The replay will be available for 90 days following the event.<\/p>\n<p>\n        <strong>About Kyntra Bio<\/strong><br \/>\n        <br \/>Kyntra Bio is a biopharmaceutical company focused on development of novel therapies in oncology and rare disease. Roxadustat (\u7231\u745e\u5353<sup>\u00ae<\/sup>, EVRENZO\u2122) is currently approved in\u00a0Europe,\u00a0Japan, China, and numerous other countries for the treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis. The Company continues to evaluate the development plan for the Phase 3 trial of roxadustat in anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) in the\u00a0U.S.\u00a0FG-3246 (also known as FOR46), a first-in-class antibody-drug conjugate (ADC) targeting CD46, is in Phase 2 development for the treatment of metastatic castration-resistant prostate cancer. This program also includes the development of FG-3180, an associated CD46-targeted PET biomarker.\u00a0For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mp-DwgX7nkE40q50poVdy8DnF4DDzN1MyqpTv__J5ZFkXvOwiN-1IV9XQ4s7ME20XgdOra-BjYD3-R6ko2eWeSDEMLgdV3pyNJ2lC8APJiiteRWLmBjWBiZEWcFLOzfpJTk39-9sjkLNlz9cV2L-2k9Xy0IqaADXbx-UvMjTbjpR3jo8QCXd4NGnVLF4v4dyPgbdEdIu4czRVoxic6FnRN6UJr_O5ui8lU4Siz81XkfC2p9oPpUXheYjIIXmpBMbbkm2pfUTwWf7nZpKe6tOnw==\" rel=\"nofollow\" target=\"_blank\">www.kyntrabio.com<\/a>.<\/p>\n<p>\n        <strong>For Investor Inquiries:<\/strong><br \/>\n        <br \/>David DeLucia, CFA<br \/>Senior Vice President and Chief Financial Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OuYG9N7HQKaq5ABqz8MBNXWSFFjw3fJP5luoMNUGN4XQ-lrMLNcB-SalGlBJ4PJUb9sJ7w772HJeyyspQt1Q5U3BAoO9YaefL8i2KXtofM0s-4hA4Z5Lr2vLZeMJ_NcjGgRZU_8ldediozGYXw4lftnbTW3WkgOitqjqUpNJ1YN4dwvtA0z9U3fwtNfn2QuCgc7utJqj8CQcEejxN48z5Hb5zileuWs6-XSC6QsN2pYhv8kvWED_C45DG_-7rKsSNaPQz2wj4GRMQ4oAlRsCSg==\" rel=\"nofollow\" target=\"_blank\">ir@kyntrabio.com<\/a><strong>\u00a0<\/strong><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk3MCM3ODE0MjA4IzIwMDc5NjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODU3NTM2ZWMtNjk3YS00MDliLWI5YzctY2Y0Y2ExMDlhMTJmLTEwMTk1MzYtMjAyNi0wOS0wMi1lbg==\/tiny\/Kyntra-Bio.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO, Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Kyntra Bio (Nasdaq: KYNB) today announced that the company\u2019s management will be attending and presenting at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026, in New York, NY. Thane Wettig, Chief Executive Officer of Kyntra Bio, will deliver a company presentation on Tuesday, September 15 at 4:00 PM ET. A live webcast of the presentation will be available\u00a0here. Kyntra Bio\u2019s management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright. The live audio webcast of the event will also be available to investors and other interested parties on the \u201cEvents &amp; Presentations\u201d section of the Kyntra Bio &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-999740","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Kyntra Bio (Nasdaq: KYNB) today announced that the company\u2019s management will be attending and presenting at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026, in New York, NY. Thane Wettig, Chief Executive Officer of Kyntra Bio, will deliver a company presentation on Tuesday, September 15 at 4:00 PM ET. A live webcast of the presentation will be available\u00a0here. Kyntra Bio\u2019s management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright. The live audio webcast of the event will also be available to investors and other interested parties on the \u201cEvents &amp; Presentations\u201d section of the Kyntra Bio &hellip; Continue reading &quot;Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T12:41:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk3MCM3ODE0MjA4IzIwMDc5NjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference\",\"datePublished\":\"2026-09-02T12:41:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\"},\"wordCount\":287,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTk3MCM3ODE0MjA4IzIwMDc5NjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\",\"name\":\"Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTk3MCM3ODE0MjA4IzIwMDc5NjM=\",\"datePublished\":\"2026-09-02T12:41:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTk3MCM3ODE0MjA4IzIwMDc5NjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTk3MCM3ODE0MjA4IzIwMDc5NjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk","og_description":"SAN FRANCISCO, Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Kyntra Bio (Nasdaq: KYNB) today announced that the company\u2019s management will be attending and presenting at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026, in New York, NY. Thane Wettig, Chief Executive Officer of Kyntra Bio, will deliver a company presentation on Tuesday, September 15 at 4:00 PM ET. A live webcast of the presentation will be available\u00a0here. Kyntra Bio\u2019s management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright. The live audio webcast of the event will also be available to investors and other interested parties on the \u201cEvents &amp; Presentations\u201d section of the Kyntra Bio &hellip; Continue reading \"Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-02T12:41:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk3MCM3ODE0MjA4IzIwMDc5NjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference","datePublished":"2026-09-02T12:41:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"},"wordCount":287,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk3MCM3ODE0MjA4IzIwMDc5NjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","name":"Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk3MCM3ODE0MjA4IzIwMDc5NjM=","datePublished":"2026-09-02T12:41:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk3MCM3ODE0MjA4IzIwMDc5NjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk3MCM3ODE0MjA4IzIwMDc5NjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kyntra-bio-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=999740"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999740\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=999740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=999740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=999740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}